|
Volumn 17, Issue 3, 1993, Pages 333-344
|
Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
6 (4 FLUOROPHENYL) 2,3 DIHYDRO 5 (4 PYRIDYL)IMIDAZO[2,1 B]THIAZOLE;
HISTAMINE;
LEUKOTRIENE B4;
LEUKOTRIENE C4;
PHOSPHODIESTERASE INHIBITOR;
ROLIPRAM;
ZAPRINAST;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
INFLAMMATION;
MALE;
MAST CELL;
MONOCYTE;
MOUSE;
NEUTROPHIL;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
ANIMAL;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARACHIDONIC ACID;
CALCIMYCIN;
CELLS, CULTURED;
COMPARATIVE STUDY;
EAR, EXTERNAL;
EICOSANOIDS;
FORSKOLIN;
HISTAMINE RELEASE;
HUMAN;
IMIDAZOLES;
INFLAMMATION;
LEUKOTRIENE B4;
MALE;
MAST CELLS;
MICE;
MICE, INBRED BALB C;
MONOCYTES;
NADOLOL;
NAPROXEN;
NEUTROPHILS;
PHOSPHODIESTERASE INHIBITORS;
PHOSPHORIC DIESTER HYDROLASES;
PURINONES;
PYRAZOLES;
PYRROLIDINONES;
RECEPTORS, ADRENERGIC, BETA;
ROLIPRAM;
SRS-A;
THIAZOLES;
ANIMALIA;
MURINAE;
|
EID: 0027325031
PISSN: 03603997
EISSN: 15732576
Source Type: Journal
DOI: 10.1007/BF00918994 Document Type: Article |
Times cited : (74)
|
References (23)
|